S&P 500   3,288.54 (+0.38%)
DOW   28,856.30 (+0.46%)
QQQ   222.68 (+0.56%)
AAPL   326.83 (+2.88%)
FB   223.47 (+2.61%)
MSFT   168.58 (+1.89%)
GOOGL   1,462.82 (+0.85%)
AMZN   1,868.15 (+0.80%)
CGC   23.67 (-1.04%)
NVDA   246.99 (-0.40%)
BABA   213.55 (+1.57%)
MU   55.67 (-1.42%)
GE   12.92 (+10.06%)
TSLA   584.76 (+3.15%)
AMD   47.38 (-6.23%)
T   37.18 (-3.63%)
ACB   1.93 (-2.03%)
F   8.89 (-0.89%)
NFLX   341.96 (-1.88%)
PRI   120.87 (+0.19%)
DIS   136.47 (-1.37%)
GILD   64.44 (+0.12%)
S&P 500   3,288.54 (+0.38%)
DOW   28,856.30 (+0.46%)
QQQ   222.68 (+0.56%)
AAPL   326.83 (+2.88%)
FB   223.47 (+2.61%)
MSFT   168.58 (+1.89%)
GOOGL   1,462.82 (+0.85%)
AMZN   1,868.15 (+0.80%)
CGC   23.67 (-1.04%)
NVDA   246.99 (-0.40%)
BABA   213.55 (+1.57%)
MU   55.67 (-1.42%)
GE   12.92 (+10.06%)
TSLA   584.76 (+3.15%)
AMD   47.38 (-6.23%)
T   37.18 (-3.63%)
ACB   1.93 (-2.03%)
F   8.89 (-0.89%)
NFLX   341.96 (-1.88%)
PRI   120.87 (+0.19%)
DIS   136.47 (-1.37%)
GILD   64.44 (+0.12%)
S&P 500   3,288.54 (+0.38%)
DOW   28,856.30 (+0.46%)
QQQ   222.68 (+0.56%)
AAPL   326.83 (+2.88%)
FB   223.47 (+2.61%)
MSFT   168.58 (+1.89%)
GOOGL   1,462.82 (+0.85%)
AMZN   1,868.15 (+0.80%)
CGC   23.67 (-1.04%)
NVDA   246.99 (-0.40%)
BABA   213.55 (+1.57%)
MU   55.67 (-1.42%)
GE   12.92 (+10.06%)
TSLA   584.76 (+3.15%)
AMD   47.38 (-6.23%)
T   37.18 (-3.63%)
ACB   1.93 (-2.03%)
F   8.89 (-0.89%)
NFLX   341.96 (-1.88%)
PRI   120.87 (+0.19%)
DIS   136.47 (-1.37%)
GILD   64.44 (+0.12%)
S&P 500   3,288.54 (+0.38%)
DOW   28,856.30 (+0.46%)
QQQ   222.68 (+0.56%)
AAPL   326.83 (+2.88%)
FB   223.47 (+2.61%)
MSFT   168.58 (+1.89%)
GOOGL   1,462.82 (+0.85%)
AMZN   1,868.15 (+0.80%)
CGC   23.67 (-1.04%)
NVDA   246.99 (-0.40%)
BABA   213.55 (+1.57%)
MU   55.67 (-1.42%)
GE   12.92 (+10.06%)
TSLA   584.76 (+3.15%)
AMD   47.38 (-6.23%)
T   37.18 (-3.63%)
ACB   1.93 (-2.03%)
F   8.89 (-0.89%)
NFLX   341.96 (-1.88%)
PRI   120.87 (+0.19%)
DIS   136.47 (-1.37%)
GILD   64.44 (+0.12%)
Log in

LON:VCT - Victrex Share Price, Forecast & News

GBX 2,306
+16.00 (+0.70 %)
(As of 01/29/2020 02:49 PM ET)
Today's Range
2,262
Now: GBX 2,306
2,316
50-Day Range
2,290
MA: GBX 2,454.72
2,540
52-Week Range
1,813.68
Now: GBX 2,306
2,574
Volume169,335 shs
Average Volume274,177 shs
Market Capitalization£2.00 billion
P/E Ratio21.57
Dividend Yield2.47%
BetaN/A
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers. It serves automotive, aerospace, energy, manufacturing and engineering, electronics, and medical markets. Read More…

Industry, Sector and Symbol

Industry Specialty Chemicals
Sub-IndustryN/A
SectorBasic Materials
CUSIPN/A
CIKN/A
Phone+44-1253-897700

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£294 million
Cash FlowGBX 80.16 per share
Book ValueGBX 534.90 per share

Profitability

Miscellaneous

Employees921
Market Cap£2.00 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive VCT News and Ratings via Email

Sign-up to receive the latest news and ratings for VCT and its competitors with MarketBeat's FREE daily newsletter.


Victrex (LON:VCT) Frequently Asked Questions

What is Victrex's stock symbol?

Victrex trades on the London Stock Exchange (LON) under the ticker symbol "VCT."

How often does Victrex pay dividends? What is the dividend yield for Victrex?

Victrex announced a dividend on Thursday, December 5th. Shareholders of record on Thursday, January 30th will be given a dividend of GBX 46.14 per share on Friday, February 21st. This represents a yield of 1.98%. The ex-dividend date of this dividend is Thursday, January 30th. This is an increase from Victrex's previous dividend of $13.42. The official announcement can be accessed at this link. View Victrex's Dividend History.

What price target have analysts set for VCT?

11 brokers have issued 12 month price objectives for Victrex's shares. Their forecasts range from GBX 1,940 to GBX 2,700. On average, they anticipate Victrex's share price to reach GBX 2,242.27 in the next twelve months. This suggests that the stock has a possible downside of 2.8%. View Analyst Price Targets for Victrex.

What is the consensus analysts' recommendation for Victrex?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Victrex in the last year. There are currently 2 sell ratings, 7 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Victrex.

Has Victrex been receiving favorable news coverage?

Press coverage about VCT stock has trended very positive recently, according to InfoTrie. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Victrex earned a news impact score of 3.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an effect on the stock's share price in the near term. View News Stories for Victrex.

Who are some of Victrex's key competitors?

What other stocks do shareholders of Victrex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Victrex investors own include Anglo American (AAL), Centamin (CEY), Renishaw (RSW), Hastings Group (HSTG), Rotork (ROR), Playtech (PTEC), Spirent Communications (SPT), Ashtead Group (AHT), Rio Tinto (RIO) and Quilter (QLT).

Who are Victrex's key executives?

Victrex's management team includes the folowing people:
  • Mr. Jakob O. Sigurdsson BA, MBA, CEO & Exec. Director (Age 55)
  • Mr. Richard Armitage, Group Fin. Director & Exec. Director (Age 53)
  • Mr. Timothy J. Cooper, Exec. Director of Industrial & Exec. Director
  • Dr. Martin L. Court, Exec. Director of Medical & Exec. Director (Age 57)
  • Mr. Andrew Hanson, Director of Investor Relations & Corp. Communications

How do I buy shares of Victrex?

Shares of VCT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Victrex's stock price today?

One share of VCT stock can currently be purchased for approximately GBX 2,306.

How big of a company is Victrex?

Victrex has a market capitalization of £2.00 billion and generates £294 million in revenue each year. Victrex employs 921 workers across the globe.View Additional Information About Victrex.

What is Victrex's official website?

The official website for Victrex is http://www.victrexplc.com/.

How can I contact Victrex?

Victrex's mailing address is Victrex Technology Centre , Hillhouse International,, THORNTON CLEVELEYS, FY5 4QD, United Kingdom. The company can be reached via phone at +44-1253-897700.


MarketBeat Community Rating for Victrex (LON VCT)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  471 (Vote Outperform)
Underperform Votes:  518 (Vote Underperform)
Total Votes:  989
MarketBeat's community ratings are surveys of what our community members think about Victrex and other stocks. Vote "Outperform" if you believe VCT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe VCT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel